» Articles » PMID: 19258940

Class II Radical Hysterectomy in Low-risk IB Squamous Cell Carcinoma of Cervix: a Safe and Effective Option

Overview
Date 2009 Mar 5
PMID 19258940
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: The aim of this study was to determine the outcome of class II radical hysterectomy for the treatment of a subset of patients with early cervical cancer.

Method: From September 1995 to September 2003, a total of 480 patients whose conditions were diagnosed with squamous carcinoma of the cervix with a tumor size of no greater than 2 cm and a pathological grade 1 to 2 was enrolled in a cohort study to compare class II and class III radical hysterectomy, with 240 patients in each group. Disease-free survival, overall survival, pattern of recurrences, and morbidity were the end points of observation for this study.

Results: The class II surgery group had 100.0% overall and 98.33% disease-free actuarial 5-year survival rate, whereas the class III surgery group had 100.0% overall and 97.92% disease-free actuarial 5-year survival rate (P = 0.736). Recurrence rate (2.92% in class II vs 2.50% in class III) was not significantly different in the 2 groups (P = 0.779). The operating time, postoperative length of hospital stay, and estimated blood loss at surgery were significantly lower in the group of patients who underwent class II hysterectomy (P = 0.0001, P = 0.0001, and P = 0.001, respectively). The postoperative complications were also significantly lower in patients who received class II hysterectomy.

Conclusions: In treating a subset of patients with tumor size no greater than 2 cm and grade 1 to 2 squamous cell cancer, class II and class III radical hysterectomy are equally effective, but the former has far less complications than the latter.

Citing Articles

Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.

Takekuma M J Gynecol Oncol. 2024; 35(2):e48.

PMID: 38499045 PMC: 10948994. DOI: 10.3802/jgo.2024.35.e48.


Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report.

Wang L, Liu P, Duan H, Li P, Su G, Li W Front Surg. 2023; 10:1166084.

PMID: 37123543 PMC: 10130524. DOI: 10.3389/fsurg.2023.1166084.


Treatment and Outcomes of Early and Operable Recurrent Cervical Cancer: A Prospective Study.

Mehta N, Desai S, Dhakad V, Patel D, Saldanha E Niger J Surg. 2021; 27(1):28-32.

PMID: 34012238 PMC: 8112370. DOI: 10.4103/njs.NJS_14_20.


Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer.

Chen C, Wang W, Liu P, Li P, Wang L, Jin S Cancer Manag Res. 2020; 11:10909-10919.

PMID: 32021416 PMC: 6955639. DOI: 10.2147/CMAR.S220212.


Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis.

Allanson E, Powell A, Bulsara M, Lee H, Denny L, Leung Y PLoS One. 2019; 14(7):e0217775.

PMID: 31269024 PMC: 6608935. DOI: 10.1371/journal.pone.0217775.